FNY Managed Accounts’s Bellicum Pharmaceuticals, Inc. BLCM Stock Holding History
Bought
Maintained
Sold
Other funds holding BLCM
BBA
PA
FNY Managed Accounts's BLCM Position: Q3 2015 in Review
FNY Managed Accounts sold out of Bellicum Pharmaceuticals, Inc. (BLCM) in Q3 2015, closing a stake of 400 shares — an estimated $85.1K sold.
FNY Managed Accounts first reported a position in BLCM in Q4 2014 and held it in 2 quarters. The position peaked at $92.2K in Q4 2014. 83 funds tracked by Wall St. Rank hold BLCM as of Q3 2015.
- FNY Managed Accounts reported no remaining Bellicum Pharmaceuticals, Inc. position as of Q3 2015 after selling out during the quarter.
- FNY Managed Accounts sold 400 Bellicum Pharmaceuticals, Inc. shares in Q3 2015, an estimated $85.1K.
- FNY Managed Accounts first reported a position in Bellicum Pharmaceuticals, Inc. in Q4 2014 and held it in 2 quarters.
- FNY Managed Accounts's Bellicum Pharmaceuticals, Inc. position peaked at $92.2K in Q4 2014.
- 83 funds tracked by Wall St. Rank held Bellicum Pharmaceuticals, Inc. as of Q3 2015.
Based on FNY Managed Accounts's 13F filing for Q3 2015, filed 27 Oct 2015.